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Abstract A relationship between migraine and patent foramen ovale (PFO) has been observed in relatively small series of patients so far. Furthermore, the exact mechanism underlying such an association remains unknown. In the present study we determined the prevalence of PFO by contrast-enhanced transcranial Doppler (TCD) in a group of 260 patients with migraine with aura (MA+), 74 patients with migraine without aura (MA-), and 38 patients with cluster headache (CH). One-hundred-sixty-one MA+subjects (61.9%), 12 MA-subjects (16.2%), and 14 CH-subjects (36.8%) were PFO-carriers. The association was independent on the frequency of migraine attacks and complexity of aura. Finally, among the 15 patients who had a history of at least one migraine attack occurring during a Valsalva maneuver only one subject turned out to be PFO-carrier. Our findings confirm previous observations of a link between MA+, CH, and PFO. They also suggest that such an association is independent on migraine clinical phenotype and is probably unrelated to the pathogenic mechanism of paradoxical embolism.
Materials and methods
The study group consisted of migrainous patients selected among those consecutively included in the database of the Headache Center -Istituto Clinico Città di Brescia, who were re-evaluated and underwent a PFO determination from January 2004 to December 2004. Patients fulfilling the International Headache Society diagnostic criteria [4] for MA-, MA+ and CH were considered. Only patients with moderate or severe headache intensity (Visual Analogical scale (VAS) ≥4) were included. For the purpose of the present study, the monthly frequency of migraine attacks in the subgroups of patients with MA-and MA+ as well as the complexity of aura in the subgroup of patients with MA+ were assessed in each patient and included in the analysis as phenotypic variables.
Finally, a further specific subgroup of migraine patients was selected based on the presumed triggering effect of strenuous physical exercise on headache occurrence. PFO was assessed in all patients with TCD with IV injection of agitated saline. The technique consists of the injection of 20 ml of previously shaken saline as contrast-enhancing agent into a peripheral vein, while recording the flow velocity of the middle cerebral artery, insonated through the temporal window on the right side at a depth of 50-60 mm, with a hand-held probe. The appearance of transient spikes on the velocity spectral curve within 10 s of the intravenous injection of contrast medium is considered positive for interatrial right-to-left shunt (Fig. 1) . The method has been previously validated in our institution and provides 90% sensitivity and 100% specificity, with an overall diagnostic accuracy of 95%, in comparison with transoesophageal echocardiography [5] . All contrast TCD were performed with a standard MultiDop (Esaote) device equipped with a 2-MHz transducer by two experienced examiners (MG, PZ) who were unaware of the status (MA+, MA-or CH) of the patients.
Results
The study group consisted of 372 patients (74 MA-; 260 MA+; 38 CH). PFO was detected in 161 subjects in the subgroup of patients with MA+ (61.9%), 12 subjects in the subgroup of patients with MA-(16.2%), and 14 subjects in the subgroup of patients with CH (36.8%). When phenotype variables (frequency of migraine attack and complexity of aura) were included in the analysis and their prevalence in each subgroup compared, no significant difference was found (Table 1) . Finally, among the 15 patients who had a history of at least one migraine attack occurring during strenuous physical exercise (Valsalva manoeuvre) only one subject turned out to be a PFO-carrier. 
Discussion
Our findings support the assumption of an association between PFO and MA+. In contrast, given the low prevalence of PFO among patients with MA-, the possibility that this interatrial abnormality may have a pathogenic role in such specific subgroup seems unlikely. Based on the results of the present study, the hypothesis of an influence of PFO on the pathogenesis of CH is also plausible. Our observation of a negative PFO-MA-association is apparently inconsistent with the results of recent observational studies in which a reduction of the frequency of migraine attacks was found after percutaneous closure of PFO in both the subgroups of patients with MA+ and MA- [6] . Although we cannot rule out the possibility of an underpowered analysis given the relatively small number of MA-patients in our group, it might be that the beneficial effect of PFO-closure on MAmay be dependent on additional, and still unknown, coexisting factors, such as, for instance, the clinical presentation of disease. Although this is biologically plausible, stratification for the phenotypic subcategories we identified did not change our results. The same is true for the potential role of paradoxical embolism. As no interaction was observed among migraine occurrence, the triggering effect of Valsalva manoeuvre and PFO, we do not believe that such a mechanism may have any pathogenic influence. These findings prompt speculation that factors different from those predicted by phenotype might be operant in the complex relation between PFO and migraine. Overall, the exact pathogenic role of PFO in migrainous disorders remains debatable. On the basis of these observations, a therapeutical randomised case-control trial of percutaneous PFO closure in patients with different migraine subtypes has been designed and will be carried out in our institution.
